This decommissioned ERA site remains active temporarily to support our final migration steps to https://ualberta.scholaris.ca, ERA's new home. All new collections and items, including Spring 2025 theses, are at that site. For assistance, please contact erahelp@ualberta.ca.
Search
Skip to Search Results- 2siRNA therapy
- 1Acute leukemia
- 1Combination therapy
- 1Polyethylenimine
- 1Polyethylenimine (PEI)
- 1breast cancer
-
Designing Nanomedicines for Breast Cancer Therapy: New Synthetic lipopolymers and Optimization of siRNA Formulations against Therapeutic Targets
DownloadFall 2024
In 2020, breast cancer became the most commonly diagnosed cancer worldwide. Conventional therapies like radiotherapy, chemotherapy and surgery have significant limitations and side effects that are mainly due to their inability to specifically target cancerous cells. Alternatively, gene therapy...
-
Spring 2021
The nuclear transcription factor, Signal Transducer and Activator of Transcription 5 (STAT5) is one of the key drivers of Acute Lymphoblastic Leukemia (ALL), the most common childhood cancer, that promotes initiation, maintenance and progression to more aggressive stages of the malignancy by...